Direct-to-patient (DTP) models are transforming clinical trial logistics, with researchers able to better reach, recruit and retain qualified study participants by delivering treatment services when and where it is most convenient for the patient. This personalized care approach has proven effective in increasing patient satisfaction and improving recruitment and retention rates, leading to cost savings, shorter development timelines and improved health outcomes.
Supporting a Patient-Centric Supply Chain
The continued shift toward DTP trials presents additional supply chain complexity, requiring the coordination of various systems and stakeholders to reach patients at the right time – at their preferred location.
Yourway is helping to lead the charge toward a more patient-centric supply chain by providing fully integrated solutions that enable researchers and developers to bring promising therapies to market, while promoting the maintenance of patient populations by providing materials and care in a capacity convenient for them.
Direct to Patient Capabilities
- Integrated packaging, storage and distribution services
- Temperature-controlled packaging and logistics for protection to and from patients’ homes
- Streamlined collection and return of biological samples
- Ability to serve global patient populations, including those in remote geographies
Staying Ahead of COVID-19
Clinical Supply Chain
Comparator Drug Sourcing & Ancillary Materials
Warehousing & Inventory Management
Integrated Project Management
Tell us about your project
Discover how our global supply chain expertise and integrated solutions can enhance your clinical research.